Heparin for Radial Artery Occlusion
(EASY-Heparin Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether heparin, a common blood thinner, is always necessary after certain heart procedures using the radial artery in the wrist. Researchers compare the usual use of heparin with a more selective approach to determine which better prevents radial artery occlusion (blockage). Individuals scheduled for a diagnostic heart procedure through the wrist's artery and able to take common blood-thinning medications like aspirin might be suitable for this study.
As an unphased trial, this study provides an opportunity to contribute to important research that could enhance future heart procedures.
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop your current medications, but you cannot participate if you are unable to take certain blood-thinning medications like aspirin, clopidogrel, or heparin.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that heparin is generally safe for preventing blockages in the radial artery after procedures like catheterization. One study found that a heparin dose higher than 75 IU/kg reduced the risk of artery blockage by 80% compared to smaller doses. This indicates that heparin effectively protects the artery and is well-tolerated. When used correctly, heparin remains safe, provided care is taken to ensure proper blood flow during and after the procedure. Overall, heparin is a reliable and safe option in similar medical situations.12345
Why are researchers excited about this trial?
Unlike the standard care for radial artery occlusion, which typically involves administering heparin for anticoagulation, this trial is exploring the effects of not using heparin after trans-radial catheterization. Researchers are excited about this approach because it could reduce the risk of bleeding complications associated with heparin use. Additionally, skipping heparin might simplify post-procedure care and improve patient comfort. This trial aims to determine if patients can achieve effective hemostasis with dual-artery compression alone, potentially changing the standard treatment protocol.
What evidence suggests that this trial's treatments could be effective for preventing radial artery occlusion?
This trial will compare the use of heparin with no heparin for preventing radial artery occlusion (RAO) after trans-radial catheterization. Studies have shown that heparin effectively lowers the risk of a blockage in the radial artery after certain heart procedures. In one study, a higher dose of heparin resulted in fewer blockages, with only 3% of patients experiencing RAO compared to 8.1% with a standard dose. Another study found heparin more effective at preventing RAO than some other treatments, with a 3.5% RAO rate in the heparin group compared to 0.5% with another treatment. These findings suggest heparin effectively prevents complications like RAO during certain medical procedures.24678
Are You a Good Fit for This Trial?
This trial is for individuals who have undergone percutaneous catheterization and are at risk of radial artery occlusion. Specific eligibility criteria details were not provided, so it's unclear who exactly can or cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a diagnostic trans-radial catheterization with either systematic or selective use of heparin
Follow-up
Participants are monitored for safety and effectiveness after treatment, including evaluation of complications
What Are the Treatments Tested in This Trial?
Interventions
- Heparin
- No heparin
Trial Overview
The study is examining if using heparin routinely (as standard care) is more effective than using it selectively to prevent blockage in the radial artery after a catheter procedure with dual-artery compression.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
No heparin administered after diagnostic only trans-radial catheterization and a dual-artery compression device for hemostasis.
Standard of care with 70-100 IU/kg of heparin after a diagnostic only trans-radial catheterization and a dual-artery compression device for hemostasis.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Olivier F. Bertrand
Lead Sponsor
Citations
Multicenter Randomized Evaluation of High Versus ...
In the high-dose heparin group, the rate of RAO was significantly lower compared with the standard-dose heparin group (27 [3.0%] vs. 75 [8.1%]; odds ratio: 0.35 ...
Radial Artery Occlusion After Transradial Interventions
The most efficacious measure in reducing RAO was higher dose of heparin, because lower doses of heparin were associated with increased RAO (risk ratio 0.36, 95% ...
3.
frontiersin.org
frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1535463/fullShort-term outcomes of unfractionated heparin vs. low ...
A significant difference was found in radial artery occlusion (RAO) rates, with 3.5% in the heparin group vs. 0.5% in the enoxaparin group (P-value 0.032). No ...
Treatment of radial artery occlusion after transradial ...
At the time of the first follow-up, the rate of recanalization of the radial artery was 31.5% after treatment with LMWH, as opposed to 5.4% in patients without ...
NCT01634438 | Heparin Dose for Radial Angiography
The main goal of this study is to determine the appropriate heparin dose to prevent wrist artery blockage and to determine risk factors for ...
Preventing Acute Radial Artery Occlusion: A Battle ... - JACC
Additionally, the investigators demonstrated an 80% risk reduction for RAO using a heparin dose >75 IU/kg, compared with a heparin dose >50 IU/ ...
the HERA-PCI Study (Heparin Early for Radial Access ...
The expected outcomes include a reduction in the incidence of radial artery occlusion after the procedure, leading to a decrease in potential complications ( ...
Radial Artery Occlusion After Transradial Cardiac ...
Comparison of the effect of intra-arterial versus intravenous heparin on radial artery occlusion after transradial catheterization. Am J Cardiol. 2009 Oct ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.